“showed a trend”

Similarly, Th1, Th2, Th17, and Treg frequencies do not significantly differ although Th2 frequencies showed a trend toward increasing within late decidual samples ( p = 0.07; Figures 5B, C ).

PHQ-9 scores, which were available for 20 patients, showed a trend toward lower mean scores in the transgender patient group (4.091 vs. 7.091, p = 0.07), although this was not statistically significant (Table 1 ).

Diabetes mellitus showed a trend towards increased risk without reaching statistical significance (OR 1.50, 95% CI 0.97–2.33, p = 0.070).

Both sexes had unaltered lathosterol levels that only showed a trend at p = 0.07 to a 103% increase.

While IGHJ4 gene usage was not associated with significant differences in prognosis (p = 0.37; Figure 2D ), patients harboring IGHJ6 gene showed a trend towards inferior five-years RFS (p = 0.07; Figure 2E ).

The superficial motor cortex showed a trend toward increased percent area of CD31+ blood vessels in NA‐CI mice (3.97% ± 1.15%, n = 9) compared to NA‐PBS mice (3.16% ± 0.81%, n = 7, p ≤ 0.07; Figure 4B ).

Survival BMI groups showed a trend to predict survival in our study cohort (p = 0.07, Fig. 2 ).

Family-based association TDT analysis of n = 448 trio CHD families showed a trend for rs1805087 in cyanotic cases ( p = 0.07), particularly driven by TOF ( p = 0.09), with preferential maternal allele transmissions ( p = 0.01, p = 0.05) in the same groups.

However, when very preterm adolescents with moderate-severe BPD were compared to very preterm ones without BPD, the first group showed a trend towards worse left ventricle function: less shortening fraction (37.5 ± 3.2% vs. 40.7 ± 4.9%, p = 0.07), less ejection fraction (68 ± 4.4% vs. 71.2 ± 5.4%, p = 0.06) and a greater E/E’ ratio (6.4 ± 0.8 vs. 4.9 ± 1.04, p = 0.01).

The BED mean brain and BED mean healthy brain showed a trend toward a significant association with at least one resected BM (p = 0.07 and p = 0.1, respectively) and the number of SRT sessions (p = 0.14 and p = 0.13, respectively).

Studies with vendor involvement showed a trend toward higher specificity than those without (0.96 vs. 0.88; p = 0.07), with similar sensitivity (0.93 vs. 0.89; p = 0.21).

2 B) and showed a trend toward increase with BCG plus hrIFN-γ ( r = 0.27 for SR; p = 0.07; not fully significant) (Fig. 2 C).

Length of VEM showed a trend to be shorter in patients experiencing complications compared to patients with no complications (8.8 ± 3.9 days vs 10.6 ± 4.9 days, p = 0.07).

At the same time, in 10 out of 18 caregivers, the family strain showed a trend to decrease (FSQ: from 14.6 ± 7.7 to 11.0 ± 6.0, p = 0.07) improving from “strongly recommended” support to within the “range of attention.” Levels of anxiety and depression were substantially unvaried in all caregivers, except for two who asked for help, and whose anxiety levels decreased.

BDHI scores had a positive correlation with f P within the BD group (R = 0.63, P = .01), and BDI scores showed a trend toward positive correlation with f P (R = 0.42, P = .07).

However, in CeD-GFD blood, 8-OHdG levels showed a trend toward a statistically significant positive correlation with miR-200 ( r = 0.37, p = 0.07) and a negative correlation with miR-1226 ( r = −0.38, p = 0.07).

Similarly, %TWL was also significantly associated with type 2 diabetes remission (OR = 0.78; 95%CI = 0.62–0.99; p = 0.04) and showed a trend for association with dyslipidemia remission (OR = 0.69; 95%CI = 0.46–1.03; p = 0.07).

Patients who received PPIs plus antibiotics showed a trend toward shorter PFS (HR 1.65, 95% CI 0.97–2.80, P = .07; Log-rank test P = .06; median, 75 days versus 209 days) and OS (HR 1.62, 95% CI 0.84–3.11, P = .15; Log-rank test P = .15; median, 211 days versus NR) compared with patients who received only PPIs ( Supplementary Figure S4 ).

Interestingly, the overall time point comparisons using the Friedman test showed a trend towards variability of gut microbiome composition related to the distinct dietary interventions (p = 0.07 for unweighted UniFrac and p = 0.19 for weighted UniFrac distances), thereby pointing to an overall dynamic microbiome community throughout the study. 3.3.

The low‐dose acetylcholine endothelial dysfunction multivariate model showed a trend toward larger dysfunction in patients with hypertension ( P =0.070) and patients treated with bioresorbable‐polymer SESs ( P =0.083).

Patients on biologic therapy reported dyspnea less frequently (biologic 1/25, 4.0%; nonbiologic 23/110, 20.9%, P = .04) but showed a trend toward increased HS flares (biologic 12/25, 48.0%; nonbiologic 32/110, 29.4%, P = .07) and longer time to COVID-19 resolution (biologic: median (interquartile range) 21 (14-31) days; nonbiologic: 14 (9-25) days, P = .07).

Interestingly, four of five patients with febrile reactions to ICB belonged to the subset of patients with high levels of T cell infiltration, and high TiL levels showed a trend toward improved PFS (p=0.07, online supplemental figure S5B ).

However, numbers of patients reaching the threshold for HADS-Anxiety doubled, which showed a trend (5 (13.5%) vs. 10 (27.03%), p = 0.07).

The LAAO group showed a trend toward having a lower estimated mRS scores at baseline to those of the NOAC group (p=0.07) and scores at 12 months post-stroke were significantly lower in the LAAO group (p<0.01), even after adjusting for several variables, including CHA 2 DS 2- VASc score, HAS-BLED score, age, gender, and other cardiovascular risk factors.

A proteasomal subunit in close proximity to the Rpn8-Rpn11 heterodimer is PSMD13 (Rpn9), which showed a trend towards upregulation (fold change = 4.2; p = 0.07).